Buradasınız

Anasayfa » Content

Nadir bir ileus nedeni olarak sklerodermanm intestinal tutulumu: Olgu sunumu

Scleroderma; As a Rare Cause of Intestinal Obstruction: Report of a Case

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Scleroderma is a systemic disease causing microvasculary injury and fibrosis accompanying with collagen deposits. Gastrointestinal system is the second most frequent involvement site after skin. pibrotic changes of smooth muscles are the primary histopathological change in scleroderma. This is the primary cause of pseudo-obstruction. Abdominal pain, distention, nausea, vomiting, constipation, and fecal incontinence are frequent symptoms. Here we report a case of scleroderma with intestinal involvement.
Bookmark/Search this post with
Abstract (Original Language): 
Skleroderma kollogen depozitlerinin birikimiyle beraber, fibrozis ve mikrovasküler hasar oluşturan sistemik bir hastalıktır. Deriden sonra en sık gastrointestinal sistem tutulur. Sklerodermadaki primer patolojik değişiklik düz kasların fibrozis ile yer değiştirmesidir. Bu da pseudoobstrüksiyonun primer nedenidir. Karın ağrısı, bulantı, kusma, abdominal şişkinlik, konstipasyon, fekal inkontinans sık görülen semptomlardır. Bu makalede sklerodermanın intestinal tutulumu olan olgumuz sunulmaktadır.
FULL TEXT (PDF): 
PDF icon arastirmax-nadir-bir-ileus-nedeni-olarak-sklerodermanm-intestinal-tutulumu-olgu-sunumu.pdf
  • 3
33-35
  • Turkish

REFERENCES

References: 

1. Kobayashi T, Kobayashi M, Naka M, Nakijima K, Momose
A
, Toi M.:Response to octreotide ofintestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis.Gastroenterology. l988;95(4):lll4-8
2. Rohrmann CA Jr, Ricci MT, Krishnamurthy S, Schuffler MD.:Radiologic and histologic differentiation of neuromuscular disorders ofthe gastrointestinal tract:Visceral myopathies and progressive systemic sclerosis. Gastroenterelogy.l979;77(4 Pt l):664-7l
3. Schuffler MD, Beegle RG: Progressive systemic sclerosis ofthe gastrointestinal tract and hereditary hollow visceral myopathy: Two distinguishable disorders ofintestinal muscle. Eur Emerg Med. 200l;8(4):333-5
4. Ortiz-Alvarez O: Intestinal pseudo-obstuction as an initial presentation of systemic sclerosis in two children. DigDis Sci. l995;40(9): l892-90l
5. Michele A. Young, MD, Suzanne Rose, MD AND James C.Reynolds, MD: Gastrointestinal manifestations ofscleroderma. Rheumatic Disease Clinics ofNorth America l996;22(4):797-8l3-8l7
6. Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML.:Advenced scleroderma bowel:Complications and management. AJRAm Roentgenol l984;l43(5):933-
4l
7. A.V. Emmanuel, A.G. Shand and M.A. Kamm: Erythromycin for the treatment of chronic intestinal pseudo-obstruction: Description of six cases with a positive response. Aliment Pharmacol Ther
2004;l9:687-693
8. Venizelos ID, Shousha S, Bull TB , Parkins RA.: Chronic intestinal pseudo-obtruction in two patients. Overlap of features of systemic sclerosis and visceral myopathy. J Rheumatol. l988;l5(5):869-74.
9. Exadaktylos A, Papagrigoriadis S.: Chronic constipation-a lethal danger in patients with systemic scleroderma. Br J Rheumatol. l997;36(2):280-4
10. Verne GN, Eaker EY, Hardy E, Sninsky CA.: Effect ofoctreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. İnternMed. l993;32(7):607-9

Thank you for copying data from http://www.arastirmax.com